Tags: Drug.

Tesofensine (NS2330) is a serotonin–noradrenaline–dopamine reuptake inhibitor from the phenyltropane family of drugs which is being developed for the treatment of obesity. The right to develop and market tesofensine is held by NeuroSearch a Danish pharmaceutical company.

Tesofensine_chemical_structure.png
ATC prefix
None
Bioavailability
90.0
CAS number
195875-84-4
FDA UNII code
BLH9UKX9V1
IUPAC name
(1R2R3S)-3-(34-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane
PubChem
11370864

Loading...

This page contains content from the copyrighted Wikipedia article "Tesofensine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.